ExpreS2ion’s Licensee, VaxInnate, is Winding Down Operations
Horsholm, Denmark, February 9, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, announces that VaxInnate Corporation (“VaxInnate”), a US based research licensee, is winding down its operations. This in effect terminates the Research License Agreement announced September 20, 2016. As all payments was received up-front, this has no financial impact on ExpreS2ion.The Research License Agreement On September 20, 2016, ExpreS2ion and VaxInnate announced the signing of a new Research License Agreement (“RLA”), granting